Clinical Trials
4 trialsNCT03113695 2022-07-05
Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome
University of California, San Diego
Phase 1 Completed
NCT02721043 2021-01-11
Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies
Icahn School of Medicine at Mount Sinai
Phase 1 Completed
NCT00046735 2019-11-18
Phase 1 Study OF CDC-501 in Patients With Solid Tumors
Celgene
Phase 1 Completed
NCT01750983 2019-02-25
Ipilimumab and Lenalidomide in Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Completed